Published in J Acquir Immune Defic Syndr on August 15, 2012
Reach and cost-effectiveness of the PrePex device for safe male circumcision in Uganda. PLoS One (2013) 1.91
Cost analysis of integrating the PrePex medical device into a voluntary medical male circumcision program in Zimbabwe. PLoS One (2014) 1.76
Attitudes, perceptions and potential uptake of male circumcision among older men in Turkana County, Kenya using qualitative methods. PLoS One (2014) 1.11
Scaling-up voluntary medical male circumcision - what have we learned? HIV AIDS (Auckl) (2014) 0.91
Understanding partial protection and HIV risk and behavior following voluntary medical male circumcision rollout in Kenya. Health Educ Res (2013) 0.88
Impact of male circumcision on the HIV epidemic in Papua New Guinea: a country with extensive foreskin cutting practices. PLoS One (2014) 0.87
Responding to Changes in HIV Policy: Updating and Enhancing the Families Matter! Curriculum. Health Educ J (2015) 0.75
Women's knowledge and perception of male circumcision before and after its roll-out in the South African township of Orange Farm from community-based cross-sectional surveys. PLoS One (2017) 0.75
Factors associated with married women's support of male circumcision for HIV prevention in Uganda: a population based cross-sectional study. BMC Public Health (2016) 0.75
Making voluntary medical male circumcision a viable HIV prevention strategy in high prevalence countries by engaging the traditional sector. Crit Public Health (2015) 0.75
Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36
Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med (2005) 42.71
Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med (2000) 41.18
Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet (2007) 38.98
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet (2007) 37.69
Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet (1989) 11.39
Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med (2002) 10.80
Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS (2000) 8.94
Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med (2009) 8.26
Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Med (2011) 7.56
A study of environmental factors in carcinoma of the cervix. Am J Obstet Gynecol (1954) 7.23
Male circumcision and HIV infection: 10 years and counting. Lancet (1999) 6.63
How does male circumcision protect against HIV infection? BMJ (2000) 5.64
Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev (2009) 4.86
Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in Orange Farm, South Africa. J Infect Dis (2009) 4.63
Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making? PLoS Med (2009) 4.05
A possible explanation for heterosexual male infection with AIDS. N Engl J Med (1986) 3.68
Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am J Pathol (2002) 3.66
Geographical patterns of male circumcision practices in Africa: association with HIV seroprevalence. Int J Epidemiol (1990) 3.63
Effect of circumcision of HIV-negative men on transmission of human papillomavirus to HIV-negative women: a randomised trial in Rakai, Uganda. Lancet (2011) 3.52
Male circumcision and HIV infection in four cities in sub-Saharan Africa. AIDS (2001) 3.33
Safety and efficacy of the PrePex device for rapid scale-up of male circumcision for HIV prevention in resource-limited settings. J Acquir Immune Defic Syndr (2011) 3.19
The relationship between male circumcision and HIV infection in African populations. AIDS (1989) 3.02
The effectiveness of male circumcision for HIV prevention and effects on risk behaviors in a posttrial follow-up study. AIDS (2012) 2.92
Potential HIV-1 target cells in the human penis. AIDS (2006) 2.84
Risk compensation is not associated with male circumcision in Kisumu, Kenya: a multi-faceted assessment of men enrolled in a randomized controlled trial. PLoS One (2008) 2.43
Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa. J Infect Dis (2009) 2.23
One-arm, open-label, prospective, cohort field study to assess the safety and efficacy of the PrePex device for scale-up of nonsurgical circumcision when performed by nurses in resource-limited settings for HIV prevention. J Acquir Immune Defic Syndr (2013) 2.18
The effects of circumcision on the penis microbiome. PLoS One (2010) 2.15
HIV-1 target cells in foreskins of African men with varying histories of sexually transmitted infections. Am J Clin Pathol (2006) 2.10
Foreskin surface area and HIV acquisition in Rakai, Uganda (size matters). AIDS (2009) 2.01
Neonatal circumcision: a review of the world's oldest and most controversial operation. Obstet Gynecol Surv (2004) 1.89
The Shang Ring device for adult male circumcision: a proof of concept study in Kenya. J Acquir Immune Defic Syndr (2011) 1.80
Circumcision status and incident herpes simplex virus type 2 infection, genital ulcer disease, and HIV infection. AIDS (2012) 1.44
Foreskin inflammation is associated with HIV and herpes simplex virus type-2 infections in Rakai, Uganda. AIDS (2009) 1.21
Multiple human papillomavirus infections and type competition in men. J Infect Dis (2011) 1.02
The role of the foreskin in male circumcision: an evidence-based review. Am J Reprod Immunol (2010) 1.01
Male circumcision and herpes simplex virus type 2 infection in female partners: a randomized trial in Rakai, Uganda. J Infect Dis (2011) 0.99
The effect of medical male circumcision on urogenital Mycoplasma genitalium among men in Kisumu, Kenya. Sex Transm Dis (2012) 0.97
Comparative periurethral bacteriology of uncircumcised and circumcised males. Genitourin Med (1997) 0.93
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet (2007) 37.69
Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep (2005) 8.91
Voluntary medical male circumcision: modeling the impact and cost of expanding male circumcision for HIV prevention in eastern and southern Africa. PLoS Med (2011) 7.56
Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet (2009) 6.80
The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med (2006) 6.53
Female genital mutilation and obstetric outcome: WHO collaborative prospective study in six African countries. Lancet (2006) 5.81
Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial. PLoS Clin Trials (2007) 4.93
Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. AIDS (2006) 4.23
Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet (2010) 4.23
Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections. Lancet (2004) 4.13
Evaluation of the PIMA point-of-care CD4 analyzer in VCT clinics in Zimbabwe. J Acquir Immune Defic Syndr (2010) 3.45
The effects of local review on informed consent documents from a multicenter clinical trials consortium. Control Clin Trials (2003) 3.30
Sampling-based approaches to improve estimation of mortality among patient dropouts: experience from a large PEPFAR-funded program in Western Kenya. PLoS One (2008) 3.19
Achieving the WHO/UNAIDS antiretroviral treatment 3 by 5 goal: what will it cost? Lancet (2004) 3.14
The safety of adult male circumcision in HIV-infected and uninfected men in Rakai, Uganda. PLoS Med (2008) 2.79
The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries. Science (2006) 2.76
Changes in the etiology of sexually transmitted diseases in Botswana between 1993 and 2002: implications for the clinical management of genital ulcer disease. Clin Infect Dis (2005) 2.55
Towards universal access to HIV prevention, treatment, care, and support: the role of tuberculosis/HIV collaboration. Lancet Infect Dis (2006) 2.48
Antiretroviral therapy in prevention of HIV and TB: update on current research efforts. Curr HIV Res (2011) 2.45
Pharmacokinetics of rifapentine at 600, 900, and 1,200 mg during once-weekly tuberculosis therapy. Am J Respir Crit Care Med (2004) 2.40
MTN-001: randomized pharmacokinetic cross-over study comparing tenofovir vaginal gel and oral tablets in vaginal tissue and other compartments. PLoS One (2013) 2.39
Voluntary medical male circumcision: an introduction to the cost, impact, and challenges of accelerated scaling up. PLoS Med (2011) 2.37
Voluntary medical male circumcision: translating research into the rapid expansion of services in Kenya, 2008-2011. PLoS Med (2011) 2.31
Vaginal microbicides and the prevention of HIV transmission. Lancet Infect Dis (2008) 2.25
Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol (2002) 2.18
Voluntary medical male circumcision: matching demand and supply with quality and efficiency in a high-volume campaign in Iringa Region, Tanzania. PLoS Med (2011) 2.12
Introducing a multi-site program for early diagnosis of HIV infection among HIV-exposed infants in Tanzania. BMC Pediatr (2010) 2.09
Voluntary medical male circumcision: strategies for meeting the human resource needs of scale-up in southern and eastern Africa. PLoS Med (2011) 2.08
Foreskin surface area and HIV acquisition in Rakai, Uganda (size matters). AIDS (2009) 2.01
Back to basics in HIV prevention: focus on exposure. BMJ (2003) 1.99
Male circumcision and risk of HIV infection in women: a systematic review and meta-analysis. Lancet Infect Dis (2009) 1.99
The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies. PLoS Med (2013) 1.98
Use of generic antiretroviral agents and cost savings in PEPFAR treatment programs. JAMA (2010) 1.98
Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test. J Clin Microbiol (2006) 1.96
Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results. JAMA (2005) 1.86
The Shang Ring device for adult male circumcision: a proof of concept study in Kenya. J Acquir Immune Defic Syndr (2011) 1.80
Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study. J Infect Dis (2012) 1.78
Adherence and acceptability in MTN 001: a randomized cross-over trial of daily oral and topical tenofovir for HIV prevention in women. AIDS Behav (2013) 1.72
Women's views on consent, counseling and confidentiality in PMTCT: a mixed-methods study in four African countries. BMC Public Health (2012) 1.69
Factors associated with HIV infection in married or cohabitating couples in Kenya: results from a nationally representative study. PLoS One (2011) 1.68
Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence. Emerg Infect Dis (2002) 1.68
Universal HIV testing and counselling in Africa. Lancet (2008) 1.67
Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens. J Acquir Immune Defic Syndr (2007) 1.66
Use of therapeutic drug monitoring for multidrug-resistant tuberculosis patients. Chest (2004) 1.63
Voluntary medical male circumcision: a qualitative study exploring the challenges of costing demand creation in eastern and southern Africa. PLoS One (2011) 1.60
Why are women still aborting outside designated facilities in metropolitan South Africa? BJOG (2005) 1.60
HIV acquisition among women from selected areas of the United States: a cohort study. Ann Intern Med (2013) 1.59
Recent patterns in population-based HIV prevalence in Swaziland. PLoS One (2013) 1.58
Voluntary medical male circumcision: logistics, commodities, and waste management requirements for scale-up of services. PLoS Med (2011) 1.58
Acceptability of early infant male circumcision as an HIV prevention intervention in Zimbabwe: a qualitative perspective. PLoS One (2012) 1.56
Sexual satisfaction of women partners of circumcised men in a randomized trial of male circumcision in Rakai, Uganda. BJU Int (2009) 1.54
Vienna Declaration: a call for evidence-based drug policies. Lancet (2010) 1.52
Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women. AIDS (2006) 1.51
Voluntary medical male circumcision: a framework analysis of policy and program implementation in eastern and southern Africa. PLoS Med (2011) 1.51
The impact of age on the epidemiology of incomplete abortions in South Africa after legislative change. BJOG (2005) 1.49
Reducing the burden of HIV/AIDS in infants: the contribution of improved diagnostics. Nature (2006) 1.48
Randomized trial of the Shang Ring for adult male circumcision with removal at one to three weeks: delayed removal leads to detachment. J Acquir Immune Defic Syndr (2012) 1.43
On-site rapid antenatal syphilis screening with an immunochromatographic strip improves case detection and treatment in rural South African clinics. Sex Transm Dis (2007) 1.39
Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives? J Int AIDS Soc (2011) 1.36
Associations between mode of HIV testing and consent, confidentiality, and referral: a comparative analysis in four African countries. PLoS Med (2012) 1.35
Estimating the Cost of Early Infant Male Circumcision in Zimbabwe: Results From a Randomized Noninferiority Trial of AccuCirc Device Versus Mogen Clamp. J Acquir Immune Defic Syndr (2015) 1.35
Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities. J Int AIDS Soc (2010) 1.35
Prevalence and factors associated with knowledge of and willingness for male circumcision in rural Zimbabwe. Trop Med Int Health (2011) 1.34
Obesity and immune cell counts in women. Metabolism (2007) 1.31
Anthrax postexposure prophylaxis in postal workers, Connecticut, 2001. Emerg Infect Dis (2002) 1.27
Challenges of a hidden epidemic: HIV prevention among women in the United States. J Acquir Immune Defic Syndr (2010) 1.27
Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women. J Infect Dis (2013) 1.25
Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS). AIDS Patient Care STDS (2009) 1.25
The occurrence of vaginal infections among HIV-infected and high-risk HIV-uninfected women: longitudinal findings of the women's interagency HIV study. J Acquir Immune Defic Syndr (2006) 1.24
Fat distribution in HIV-infected women in the United States: DEXA substudy in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr (2005) 1.20
Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments. CMAJ (2003) 1.20
Confirmatory real-time PCR assay for human papillomavirus (HPV) type 52 infection in anogenital specimens screened for HPV infection with the linear array HPV genotyping test. J Clin Microbiol (2007) 1.20
Status of voluntary medical male circumcision in Kenya: findings from 2 nationally representative surveys in Kenya, 2007 and 2012. J Acquir Immune Defic Syndr (2014) 1.18
Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr (2008) 1.17
Lessons learned from scale-up of voluntary medical male circumcision focusing on adolescents: benefits, challenges, and potential opportunities for linkages with adolescent HIV, sexual, and reproductive health services. J Acquir Immune Defic Syndr (2014) 1.15
The association of bone mineral density with HIV infection and antiretroviral treatment in women. Antivir Ther (2007) 1.13
Reducing the burden of sexually transmitted infections in resource-limited settings: the role of improved diagnostics. Nature (2006) 1.13
Self-sampling is associated with increased detection of human papillomavirus DNA in the genital tract of HIV-seropositive women. Clin Infect Dis (2005) 1.13
The challenge of defining standards of prevention in HIV prevention trials. J Med Ethics (2010) 1.09
Relationship between smoking and human papillomavirus infections in HIV-infected and -uninfected women. J Infect Dis (2004) 1.09
Complex emergencies, HIV, and substance use: no "big easy" solution. Subst Use Misuse (2006) 1.08
Improvement in healing and reduction in HIV shedding with episodic acyclovir therapy as part of syndromic management among men: a randomized, controlled trial. J Infect Dis (2009) 1.08
Disclosure, knowledge of partner status, and condom use among HIV-positive patients attending clinical care in Tanzania, Kenya, and Namibia. AIDS Patient Care STDS (2013) 1.07
Effect of contraceptive methods on natural history of HIV: studies from the Mombasa cohort. J Acquir Immune Defic Syndr (2005) 1.06
Burden of HIV among primary school children and feasibility of primary school-linked HIV testing in Harare, Zimbabwe: a mixed methods study. AIDS Care (2013) 1.04